DoveBid to conduct auction for Pfizer Japan
DoveBid, a USA-based global provider of capital asset auction and valuation services, will conduct a series of biotechnology and pharmaceutical laboratory equipment sales via a featured on-line auction for Pfizer Japan's laboratory located in Nagoya, Japan.
The first on-line auction is scheduled to be conducted January 30 and will end January 31. Featured items in the first sale will include over 350 pieces of biotechnology laboratory and R&D equipment. Multiple on-line auctions for Pfizer Japan are scheduled up to May.
"On-line auctions are very popular in the USA and it has started to prevail in the Japanese market. We are working hard to support our clients, not only in biotech and pharmaceutical industries, but also in other industries, to manage their surplus assets by leveraging our state-of-the-art on-line systems," said Yusuke Uchiyama, account executive of DoveBid, Japan.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze